As per the Department of Health (DOH) Department Circular 2024 -0308 published 31 July 2024, the Secretary of Health (SOH) fully concurs with the HTA Council recommendation on the non-financing and non-inclusion of Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide in the list of larvicides to be used by the Aedes Borne Viral Diseases (Dengue) Prevention and Control Program of the Department of Health.
The negative HTA Council recommendation was due to the unavailability of sufficient clinical evidence on its efficacy, effectiveness, and safety at this point.
The HTA Council suggests further studies to be conducted in order to provide the needed evidence that addresses its decision criteria based on the UHC Law. Supporting evidence that informed the recommendation of the HTA Council can be found in the evidence summary and the HTA Report accessible through the following documents: